INTRODUCTION: In contrast to skin cancer and lymphoproliferative disorders, de-novo lung allograft cancer is seldom reported after lung transplantation. CASE REPORT: A 19-year-old patient with severe pulmonary hypertension listed urgently for lung transplantation underwent successful bilateral lung transplant procedure receiving lungs from a 55-year-old donor with a smoking history of 30 pack years. After 3.5 years of lung transplantation, a locally advanced squamous cell carcinoma in the left lung allograft was diagnosed. Extended (intra-pericardial) left pneumonectomy was successfully performed, but the patient died a few weeks later due to acute respiratory distress syndrome. CONCLUSION: Usage of extended criteria donors seems a succes...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
During the last 2 decades, long-term survival after lung transplantation has significantly improved....
Lung transplantation is an effective and safe therapy for carefully selected patients suffering from...
AbstractWith the increase in the number of lung transplants, it is expected that there will be a cor...
Patients receiving lung transplantation are at increasing risk for the development of cancer due to ...
Background and objective Lung transplantation is an efficient therapeutic option for patients with e...
Currently, lung transplantation is the standard of care for patients with end-stage lung disease, wi...
A recent history of malignancy is an absolute contraindication for lung transplantation according to...
Hypothesis :That aggressive surgical treatment of lung cancer (LC) is justified by stage-based outco...
BackgroundLung cancer may occur in the lung transplant population because many patients are former s...
Patients under consideration for lung transplantation as treatment for end-stage lung diseases such ...
International audienceObjectives: Solid organ transplantation is an accepted treatment for end-stage...
Magnus Ekström,1 Gerdt C Riise,2 Hanan A Tanash3 1Department of Clinical Sciences, Division of...
AbstractObjective: We sought to examine our management and outcome of lung carcinoma occurring after...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
During the last 2 decades, long-term survival after lung transplantation has significantly improved....
Lung transplantation is an effective and safe therapy for carefully selected patients suffering from...
AbstractWith the increase in the number of lung transplants, it is expected that there will be a cor...
Patients receiving lung transplantation are at increasing risk for the development of cancer due to ...
Background and objective Lung transplantation is an efficient therapeutic option for patients with e...
Currently, lung transplantation is the standard of care for patients with end-stage lung disease, wi...
A recent history of malignancy is an absolute contraindication for lung transplantation according to...
Hypothesis :That aggressive surgical treatment of lung cancer (LC) is justified by stage-based outco...
BackgroundLung cancer may occur in the lung transplant population because many patients are former s...
Patients under consideration for lung transplantation as treatment for end-stage lung diseases such ...
International audienceObjectives: Solid organ transplantation is an accepted treatment for end-stage...
Magnus Ekström,1 Gerdt C Riise,2 Hanan A Tanash3 1Department of Clinical Sciences, Division of...
AbstractObjective: We sought to examine our management and outcome of lung carcinoma occurring after...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
Late-onset noninfectious pulmonary complications (LONIPCs) affect 6% of allogeneic stem cell transpl...
During the last 2 decades, long-term survival after lung transplantation has significantly improved....